Video yükleniyor...
Video Yüklenemedi
DR. OZ: “This is the most powerful executive order on pharmacy pricing and healthcare ever in the history of our nation.” Dr. Oz says President Trump’s executive order to slash drug prices is a game-changer. Under the new plan, Americans will finally pay the same prices as other countries... show more
89,008 görüntüleme • 1 yıl önce •via X (Twitter)
10 Yorum

President Trump is a once in a lifetime warrior for America. He deserves our respect.

Here’s what could get more expensive with Trump’s new tariffs.

The executive order targeting drug pricing is a necessary strike at Big Pharma’s monopoly-driven extortion. For decades, Americans have been held hostage by artificial price hikes—paying 3-4x more for insulin than other nations while HHS spending ballooned 41.7% from FY2019 to FY2024. This isn’t about “negotiation”; it’s about dismantling a rigged system where 74% of Medicare’s $1.7T budget gets funneled into chronic disease management fueled by overpriced medications. The real test? Whether CMS enforces transparency on PBM kickbacks and patent abuses that keep generics sidelined. If this order forces alignment with international reference pricing, it’s a start—but lasting reform requires gutting the regulatory capture that let this theft thrive. Taxpayers deserve more than temporary relief; they need structural overhaul.

Let’s be honest Congress was never going to do this. For decades, dems and the GOP talked tough on drug prices, held hearings, waved charts around and then took the pharma checks and did nothing. Because big pharma owns Capitol Hill. And if we don't for Congress to act, this executive order is in jeopardy!

Awaiting orders

The blowback from Big Pharma is going to be interesting. 👀

He needs to figure out the insurance issues now

I want to see what piece of shit judge will block this

But WHY do Americans consume so many pharma products? (the most in the world per capita) THAT IS THE QUESTION NO ONE IS ADDRESSING. @DrJackKruse

Now eliminate income taxes for Americans making less than $250,000.
